LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION Revision 1 April 5, 2023 TO: Honorable Sam Harless, Chair, House Committee on Health Care Reform, Select FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: HB3286 by Klick (Relating to certain prescription drug benefits under the Medicaid managed care program.), As Introduced The fiscal implications of the bill cannot be determined due to the uncertainty regarding the number of clients that would shift to non-preferred drugs as a result of exceptions to step therapy protocol. The bill would establish a process for requesting exceptions to step therapy protocol for recipients in a managed care plan. According to the Health and Human Services Commission, the bill could result in a reduction of federal and supplemental rebates due to a shift towards higher net cost non-preferred drugs. However, due to a lack of information regarding the effects on utilization, the fiscal impact cannot be determined at this time. Local Government ImpactNo fiscal implication to units of local government is anticipated. Source Agencies: b > td > 529 Health and Human Services Commission LBB Staff: b > td > JMc, NPe, ER, CST
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
Revision 1
April 5, 2023
Revision 1
Revision 1
TO: Honorable Sam Harless, Chair, House Committee on Health Care Reform, Select FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: HB3286 by Klick (Relating to certain prescription drug benefits under the Medicaid managed care program.), As Introduced
TO: Honorable Sam Harless, Chair, House Committee on Health Care Reform, Select
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB3286 by Klick (Relating to certain prescription drug benefits under the Medicaid managed care program.), As Introduced
Honorable Sam Harless, Chair, House Committee on Health Care Reform, Select
Honorable Sam Harless, Chair, House Committee on Health Care Reform, Select
Jerry McGinty, Director, Legislative Budget Board
Jerry McGinty, Director, Legislative Budget Board
HB3286 by Klick (Relating to certain prescription drug benefits under the Medicaid managed care program.), As Introduced
HB3286 by Klick (Relating to certain prescription drug benefits under the Medicaid managed care program.), As Introduced
The fiscal implications of the bill cannot be determined due to the uncertainty regarding the number of clients that would shift to non-preferred drugs as a result of exceptions to step therapy protocol.
The fiscal implications of the bill cannot be determined due to the uncertainty regarding the number of clients that would shift to non-preferred drugs as a result of exceptions to step therapy protocol.
The bill would establish a process for requesting exceptions to step therapy protocol for recipients in a managed care plan. According to the Health and Human Services Commission, the bill could result in a reduction of federal and supplemental rebates due to a shift towards higher net cost non-preferred drugs. However, due to a lack of information regarding the effects on utilization, the fiscal impact cannot be determined at this time.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: b > td > 529 Health and Human Services Commission
529 Health and Human Services Commission
LBB Staff: b > td > JMc, NPe, ER, CST
JMc, NPe, ER, CST